Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' p ... more
Waters to Acquire Andrew Alliance
Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves the use of automation technology, enabling more scientists to realize the advantages of repeatability and performance for both routine and complex laboratory workflows.
“The acquisition of Andrew Alliance broadens our technology portfolio to include advanced robotics and software that will positively impact our customers’ workflows across pharmaceuticals, life sciences and materials science markets,” commented Chris O’Connell, Chairman and Chief Executive Officer of Waters Corporation. “This move also demonstrates Waters’ commitment to deploy capital to growth-oriented acquisitions that reinforce our specialty strategy and enhance our core business.”
Andrew Alliance has approximately 40 employees in Switzerland, France and the United States.
“We are thrilled to join the Waters family,” commented Piero Zucchelli, Chief Executive Officer of Andrew Alliance. “We have found the right partner to bring our vision of connected laboratories to life. Waters’ combination of instruments and chemistries will help us accelerate the delivery of our innovative software and hardware technologies to customers as mass spectrometry increasingly moves into the hands of more and more users.”
Waters Corporation announced that it entered into a co-marketing agreement with Malvern Panalytical to advance the analysis of polymers. By pairing the Waters ® ACQUITY ® Advanced Polymer Chromatography ® (APC ™ ) System with Malvern Panalytical’s OMNISEC ® REVEAL , R&D scientists can acces ... more
Waters Corporation announced that Douglas A. Berthiaume will retire as Chairman of the Board of Directors of the Company, effective December 31, 2017. The Board of Directors has elected Christopher J. O'Connell, President and Chief Executive Officer, as its new Chairman effective January 1, ... more
Combines novel cyclic ion mobility separation with superior time-of-flight mass spectrometry ✓ Trennen Sie mit ultimativer Auflösung in der Ionenmobilität mehr als jemals zuvor für absolute Sicherheit more
Maximum performance: more analytes per injection and larger concentration ranges - on a small footprint, at an affordable price more
Our products are manufactured to industry benchmark quality requirements by our world-class manufacturing organization and supported by our highly skilled sales and support teams more
Leading researchers are discovering the promise of the SELECT SERIES™ Cyclic™ IMS. This revolutionary new instrument combines novel cyclic ion mobility (cIMS) separation with state-of-the-art, high-performance, time-of-flight mass spectrometry, to help bring you to the forefront of scientif ... more
The BioAccord system enables even users without expert knowledge to generate and evaluate LC-MS data on the spot in the biopharmaceutical lab, tasks that until now had to be performed in centralized MS laboratories. From development to QC, the system makes the analysis of biotherapeutic pro ... more
Analytical laboratories working at full capacity are faced with the challenge of ensuring a comprehensive coverage of applications while working time and cost efficiently. This balancing act is now possible thanks to the Xevo TQ-GC mass spectrometer. Your results are reproducible even with ... more
Andrew Alliance S.A. and Sartorius announced the launch of the Andrew Alliance Pipette+ system, which uniquely provides both full traceability and improved repeatability in manual pipetting for life science laboratories. Andrew Alliance, the robotics company with an innovative approach to l ... more
- 1New Indication of a Link Between Alzheimer’s and Diabetes
- 2Click... Resistant bacteria caught in the act!
- 3The relationship of proteins
- 4Nanosafety research without animal experiments
- 5DKSH extends partnership with Bruker in China
- 6Could the blood of COVID-19 patients be used to predict disease progression?
- 7Detecting antibodies with glowing proteins, thread and a smartphone
- 8RNA structures by the thousands
- 9Developing new techniques to improve atomic force microscopy
- 10High-end Microscopy Refined